查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1973951

胰岛素帮浦市场分析及预测（至2035年）：依类型、产品类型、技术、组件、应用、最终用户、功能、安装类型、设备及模式划分

Insulin Pump Market Analysis and Forecast to 2035: Type, Product, Technology, Component, Application, End User, Functionality, Installation Type, Equipment, Mode
出版日期: | 出版商: Global Insight Services | 英文 313 Pages | 商品交期: 3-5个工作天内

价格
简介目录

预计胰岛素帮浦市场规模将从2024年的85亿美元成长到2034年的198亿美元，复合年增长率约为8.8%。胰岛素帮浦市场涵盖用于糖尿病管理的持续输注胰岛素的设备。这些帮浦提供精准的剂量控制和柔软性的使用方式，有助于改善血糖控制，提高患者的生活品质。市场成长的驱动因素包括糖尿病盛行率的上升、技术的进步以及人们对糖尿病管理意识的提高。与持续血糖监测系统整合以及智慧型手机连接等创新技术对于满足个人化和便利的糖尿病护理解决方案的需求至关重要。

胰岛素帮浦市场正经历强劲成长，主要驱动力来自于技术进步和糖尿病盛行率的不断上升。无导管胰岛素帮浦展现卓越的性能，提供更便利的使用体验。传统胰岛素帮浦虽然因其公认的有效性和可靠性仍然重要，但成长速度却有所放缓。耗材细分市场，特别是输注管路和储液器，由于需要定期更换，需求显着成长。整合连续血糖监测（CGM）系统的智慧胰岛素帮浦正受到越来越多的关注，反映出市场对更全面的糖尿病管理解决方案的需求趋势。闭合迴路系统有望成为下一个最尖端科技的细分市场，因为它们能够更好地控制血糖并减少用户干预。市场也正朝着个人化、以患者为中心的解决方案转变，製造商致力于开发用户友好的介面和行动连线，以实现即时数据追踪，从而提高患者的依从性和治疗效果。

市场区隔
类型 有线泵、贴片帮浦、传统泵、一次性泵
产品 胰岛素帮浦、智慧型帮浦、迷你帮浦、植入式帮浦、体外泵
科技 持续皮下胰岛素输注，支援蓝牙连接，可连接智慧型手机，实现胰岛素自动输注，闭合迴路系统
成分 泵体、输液管路、储液器、电池、显示器
适用的 1型糖尿病、第2型糖尿病、妊娠糖尿病
最终用户 医院、居家医疗、诊所和门诊手术中心
功能 一次性使用和可重复使用
安装类型 可穿戴的和不可穿戴的
装置 监控设备、管理设备
模式 手动，自动

市场概况：

胰岛素帮浦市场充满活力，市占率分布多元化。定价策略因地区而异，并受医疗基础设施和报销政策的影响。近期推出的新产品引进了先进功能，提升了使用者体验和管理效率。这些创新对于保持竞争优势和掌握市场新机会至关重要。市场竞争激烈，主要厂商不断相互标桿，以改善产品。监管影响显着，严格的指导方针影响产品开发和核准流程。得益于技术进步和糖尿病盛行率的上升，市场呈现强劲成长动能。北美持续保持主导地位，而亚太地区则展现出巨大的成长潜力。这些地区的法规结构对于塑造市场动态和确保合规性至关重要。策略性地专注于创新并遵守监管标准，将在保持市场成长动能方面发挥关键作用。

主要趋势和驱动因素：

胰岛素帮浦市场正经历强劲成长，这主要得益于全球糖尿病盛行率的上升和医疗技术的进步。关键趋势包括人工智慧 (AI) 和机器学习技术的日益融合，以增强胰岛素帮浦的功能，实现即时血糖值监测和自动胰岛素输注。患者对能够提升便利性和生活品质的设备的需求不断增长，推动了个人化糖尿病管理解决方案的需求。此外，无线和蓝牙胰岛素帮浦的需求也激增，这些设备能够实现无缝资料传输和医护人员的远端监控。政府为提高糖尿病意识和管理水平而采取的措施也进一步促进了市场扩张。随着消费者越来越重视健康和保健，穿戴式医疗设备的普及也是推动市场成长的关键因素。新兴市场医疗基础设施不断完善，糖尿病盛行率也上升，这些市场蕴藏着许多机会。在这种不断变化的环境中，专注于创新和价格亲民的公司将更有机会赢得市场份额。

限制与挑战：

胰岛素帮浦市场面临许多重大限制和挑战。首先，胰岛素帮浦设备高成本，阻碍了其广泛应用，尤其是在发展中地区。这些地区的患者往往缺乏足够的经济能力来投资先进的糖尿病管理技术。其次，胰岛素帮浦使用复杂，操作难度高。患者需要接受全面的训练才能有效操作这些设备，这对某些患者来说可能比较困难。第三，许多医疗体系对胰岛素帮浦的保险覆盖范围有限，降低了患者选择这种治疗方法的意愿。保险政策往往优先考虑价格较低的替代方案。第四，市场上的技术进步正迅速淘汰旧型号，需要不断升级换代。患者和医疗服务提供者都难以跟上这些变化。最后，网路安全和资料隐私问题也构成挑战。随着胰岛素帮浦的互联程度越来越高，资料外洩和未授权存取的风险也随之增加，进而影响使用者信任度。

目录

第一章执行摘要

第二章 市集亮点

第三章 市场动态

  • 宏观经济分析
  • 市场趋势
  • 市场驱动因素
  • 市场机会
  • 市场限制
  • 复合年均成长率：成长分析
  • 影响分析
  • 新兴市场
  • 技术蓝图
  • 战略框架

第四章 细分市场分析

  • 市场规模及预测：依类型
    • 有线泵
    • 贴片帮浦
    • 传统泵浦
    • 一次性泵浦
  • 市场规模及预测：依产品划分
    • 胰岛素帮浦
    • 智慧泵浦
    • 小型泵浦
    • 植入式帮浦
    • 外置泵
  • 市场规模及预测：依技术划分
    • 持续皮下胰岛素输注
    • 蓝牙功能
    • 智慧型手机连线类型
    • 自动胰岛素给药系统
    • 闭合迴路系统
  • 市场规模及预测：依组件划分
    • 泵浦设备
    • 点滴器
    • 水库
    • 电池
    • 显示萤幕
  • 市场规模及预测：依应用领域划分
    • 1型糖尿病
    • 2型糖尿病
    • 妊娠糖尿病
  • 市场规模及预测：依最终用户划分
    • 医院
    • 居家照护
    • 诊所
    • 门诊手术中心
  • 市场规模及预测：依功能划分
    • 一次性的
    • 可重复使用类型
  • 市场规模及预测：依安装类型划分
    • 穿戴式装置
    • 不可穿戴
  • 市场规模及预测：依设备划分
    • 监控设备
    • 加药装置
  • 市场规模及预测：按模式
    • 手动输入
    • 自动的

第五章 区域分析

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲地区
  • 亚太地区
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳洲
    • 台湾
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 义大利
    • 其他欧洲地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非
    • 撒哈拉以南非洲
    • 其他中东和非洲地区

第六章 市场策略

  • 需求与供给差距分析
  • 贸易和物流限制
  • 价格、成本和利润率趋势
  • 市场渗透率
  • 消费者分析
  • 法规概述

第七章 竞争讯息

  • 市场定位
  • 市场占有率
  • 竞争基准
  • 主要企业的策略

第八章：公司简介

  • Tandem Diabetes Care
  • Insulet Corporation
  • Ypsomed Holding
  • SOOIL Development
  • MicroTech Medical
  • Medtrum Technologies
  • Valeritas
  • Roche Diabetes Care
  • Debiotech
  • Diabeloop
  • Beta Bionics
  • A. Menarini Diagnostics
  • Cellnovo Group
  • DANA Diabecare
  • Bigfoot Biomedical

第九章：关于我们

简介目录
Product Code: GIS33976

Insulin Pump Market is anticipated to expand from $8.5 billion in 2024 to $19.8 billion by 2034, growing at a CAGR of approximately 8.8%. The Insulin Pump Market encompasses devices designed for the continuous delivery of insulin to manage diabetes. These pumps offer precise dosing and flexibility, improving glycemic control and enhancing patient quality of life. Market growth is driven by rising diabetes prevalence, technological advancements, and increasing awareness of diabetes management. Innovations such as integration with continuous glucose monitoring systems and smartphone connectivity are pivotal, catering to the demand for personalized and convenient diabetes care solutions.

The Insulin Pump Market is experiencing robust growth, primarily driven by technological advancements and increasing diabetes prevalence. The segment of tubeless insulin pumps is leading in performance, offering enhanced convenience and user comfort. Traditional insulin pumps, while still significant, follow closely due to their established efficacy and reliability. The consumables sub-segment, particularly infusion sets and reservoirs, is witnessing substantial demand, driven by the necessity for regular replacements. Smart insulin pumps, integrating continuous glucose monitoring (CGM) systems, are gaining traction, reflecting a trend towards more holistic diabetes management solutions. Closed-loop systems, representing the forefront of innovation, are expected to be the second highest performing sub-segment, as they promise improved glycemic control and reduced user intervention. The market is also seeing a shift towards personalized and patient-centric solutions, with manufacturers focusing on user-friendly interfaces and mobile connectivity for real-time data tracking, thus enhancing patient adherence and outcomes.

Market Segmentation
TypeTethered Pumps, Patch Pumps, Traditional Pumps, Disposable Pumps
ProductInsulin Pumps, Smart Pumps, Miniature Pumps, Implantable Pumps, External Pumps
TechnologyContinuous Subcutaneous Insulin Infusion, Bluetooth-enabled, Smartphone-connected, Automated Insulin Delivery, Closed-loop Systems
ComponentPump Device, Infusion Set, Reservoir, Battery, Display Screen
ApplicationType 1 Diabetes, Type 2 Diabetes, Gestational Diabetes
End UserHospitals, Home Care, Clinics, Ambulatory Surgical Centers
FunctionalityDisposable, Reusable
Installation TypeWearable, Non-wearable
EquipmentMonitoring Devices, Delivery Devices
ModeManual, Automatic

Market Snapshot:

The insulin pump market is characterized by a dynamic landscape with diverse market share distribution. Pricing strategies vary across regions, influenced by healthcare infrastructure and reimbursement policies. Recent product launches have introduced advanced features, enhancing user experience and management efficiency. These innovations are pivotal in maintaining competitive advantage and capturing emerging opportunities in the market. Competition is intense, with key players continuously benchmarking against each other to refine their offerings. Regulatory influences are significant, with stringent guidelines impacting product development and approval processes. The market is witnessing robust growth, driven by technological advancements and increasing diabetes prevalence. North America remains a dominant force, while Asia-Pacific shows promising growth potential. Regulatory frameworks in these regions are crucial in shaping market dynamics and ensuring compliance. The strategic focus on innovation and adherence to regulatory standards will be instrumental in sustaining market momentum.

Geographical Overview:

The insulin pump market is witnessing substantial growth across various regions, each with unique characteristics. North America leads, driven by a high prevalence of diabetes and advanced healthcare infrastructure. The region's focus on innovative medical technologies and favorable reimbursement policies further propels market expansion. Europe follows, with increasing diabetes awareness and government initiatives enhancing market dynamics. The Asia Pacific region is experiencing rapid growth, supported by rising healthcare expenditures and improving medical facilities. Emerging economies like China and India are showing significant potential due to increasing diabetes cases and growing healthcare awareness. Latin America and the Middle East & Africa are also emerging as promising markets. Latin America benefits from improving healthcare systems, while the Middle East & Africa are recognizing the need for advanced diabetes management solutions. These regions present lucrative opportunities for market players aiming to expand their global footprint.

Key Trends and Drivers:

The insulin pump market is experiencing robust growth, driven by the increasing prevalence of diabetes globally and advancements in medical technologies. Key trends include the integration of artificial intelligence and machine learning to enhance pump functionality, offering real-time glucose monitoring and automated insulin delivery. The demand for personalized diabetes management solutions is rising, with patients seeking devices that offer convenience and improved quality of life. Additionally, the market is witnessing a surge in demand for wireless and Bluetooth-enabled pumps, allowing seamless data transfer and remote monitoring by healthcare professionals. Government initiatives promoting diabetes awareness and management are further propelling market expansion. The growing adoption of wearable medical devices is also a significant driver, as consumers increasingly prioritize health and wellness. Opportunities abound in emerging markets where healthcare infrastructure is improving and diabetes prevalence is rising. Companies focusing on innovation and affordability are well-positioned to capture market share in this evolving landscape.

Restraints and Challenges:

The insulin pump market confronts several significant restraints and challenges. First, the high cost of insulin pump devices impedes widespread adoption, particularly in developing regions. Patients in these areas often lack the financial resources to invest in advanced diabetes management technologies. Second, the complexity of insulin pump usage presents a barrier. Patients require comprehensive training to operate these devices effectively, which can be daunting for some. Third, there is limited reimbursement coverage for insulin pumps in many healthcare systems, deterring patients from opting for this treatment option. Insurance policies often favor less costly alternatives. Fourth, technological advancements in the market lead to rapid obsolescence of older models, creating a continuous need for upgrades. Patients and healthcare providers may find it challenging to keep pace with these changes. Lastly, concerns about cybersecurity and data privacy pose challenges. As insulin pumps become more connected, the risk of data breaches and unauthorized access increases, affecting user confidence.

Key Players:

Tandem Diabetes Care, Insulet Corporation, Ypsomed Holding, SOOIL Development, MicroTech Medical, Medtrum Technologies, Valeritas, Roche Diabetes Care, Debiotech, Diabeloop, Beta Bionics, A. Menarini Diagnostics, Cellnovo Group, DANA Diabecare, Bigfoot Biomedical

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Technology
  • 2.4 Key Market Highlights by Component
  • 2.5 Key Market Highlights by Application
  • 2.6 Key Market Highlights by End User
  • 2.7 Key Market Highlights by Functionality
  • 2.8 Key Market Highlights by Installation Type
  • 2.9 Key Market Highlights by Equipment
  • 2.10 Key Market Highlights by Mode

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Tethered Pumps
    • 4.1.2 Patch Pumps
    • 4.1.3 Traditional Pumps
    • 4.1.4 Disposable Pumps
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Insulin Pumps
    • 4.2.2 Smart Pumps
    • 4.2.3 Miniature Pumps
    • 4.2.4 Implantable Pumps
    • 4.2.5 External Pumps
  • 4.3 Market Size & Forecast by Technology (2020-2035)
    • 4.3.1 Continuous Subcutaneous Insulin Infusion
    • 4.3.2 Bluetooth-enabled
    • 4.3.3 Smartphone-connected
    • 4.3.4 Automated Insulin Delivery
    • 4.3.5 Closed-loop Systems
  • 4.4 Market Size & Forecast by Component (2020-2035)
    • 4.4.1 Pump Device
    • 4.4.2 Infusion Set
    • 4.4.3 Reservoir
    • 4.4.4 Battery
    • 4.4.5 Display Screen
  • 4.5 Market Size & Forecast by Application (2020-2035)
    • 4.5.1 Type 1 Diabetes
    • 4.5.2 Type 2 Diabetes
    • 4.5.3 Gestational Diabetes
  • 4.6 Market Size & Forecast by End User (2020-2035)
    • 4.6.1 Hospitals
    • 4.6.2 Home Care
    • 4.6.3 Clinics
    • 4.6.4 Ambulatory Surgical Centers
  • 4.7 Market Size & Forecast by Functionality (2020-2035)
    • 4.7.1 Disposable
    • 4.7.2 Reusable
  • 4.8 Market Size & Forecast by Installation Type (2020-2035)
    • 4.8.1 Wearable
    • 4.8.2 Non-wearable
  • 4.9 Market Size & Forecast by Equipment (2020-2035)
    • 4.9.1 Monitoring Devices
    • 4.9.2 Delivery Devices
  • 4.10 Market Size & Forecast by Mode (2020-2035)
    • 4.10.1 Manual
    • 4.10.2 Automatic

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Technology
      • 5.2.1.4 Component
      • 5.2.1.5 Application
      • 5.2.1.6 End User
      • 5.2.1.7 Functionality
      • 5.2.1.8 Installation Type
      • 5.2.1.9 Equipment
      • 5.2.1.10 Mode
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Technology
      • 5.2.2.4 Component
      • 5.2.2.5 Application
      • 5.2.2.6 End User
      • 5.2.2.7 Functionality
      • 5.2.2.8 Installation Type
      • 5.2.2.9 Equipment
      • 5.2.2.10 Mode
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Technology
      • 5.2.3.4 Component
      • 5.2.3.5 Application
      • 5.2.3.6 End User
      • 5.2.3.7 Functionality
      • 5.2.3.8 Installation Type
      • 5.2.3.9 Equipment
      • 5.2.3.10 Mode
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Technology
      • 5.3.1.4 Component
      • 5.3.1.5 Application
      • 5.3.1.6 End User
      • 5.3.1.7 Functionality
      • 5.3.1.8 Installation Type
      • 5.3.1.9 Equipment
      • 5.3.1.10 Mode
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Technology
      • 5.3.2.4 Component
      • 5.3.2.5 Application
      • 5.3.2.6 End User
      • 5.3.2.7 Functionality
      • 5.3.2.8 Installation Type
      • 5.3.2.9 Equipment
      • 5.3.2.10 Mode
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Technology
      • 5.3.3.4 Component
      • 5.3.3.5 Application
      • 5.3.3.6 End User
      • 5.3.3.7 Functionality
      • 5.3.3.8 Installation Type
      • 5.3.3.9 Equipment
      • 5.3.3.10 Mode
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Technology
      • 5.4.1.4 Component
      • 5.4.1.5 Application
      • 5.4.1.6 End User
      • 5.4.1.7 Functionality
      • 5.4.1.8 Installation Type
      • 5.4.1.9 Equipment
      • 5.4.1.10 Mode
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Technology
      • 5.4.2.4 Component
      • 5.4.2.5 Application
      • 5.4.2.6 End User
      • 5.4.2.7 Functionality
      • 5.4.2.8 Installation Type
      • 5.4.2.9 Equipment
      • 5.4.2.10 Mode
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Technology
      • 5.4.3.4 Component
      • 5.4.3.5 Application
      • 5.4.3.6 End User
      • 5.4.3.7 Functionality
      • 5.4.3.8 Installation Type
      • 5.4.3.9 Equipment
      • 5.4.3.10 Mode
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Technology
      • 5.4.4.4 Component
      • 5.4.4.5 Application
      • 5.4.4.6 End User
      • 5.4.4.7 Functionality
      • 5.4.4.8 Installation Type
      • 5.4.4.9 Equipment
      • 5.4.4.10 Mode
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Technology
      • 5.4.5.4 Component
      • 5.4.5.5 Application
      • 5.4.5.6 End User
      • 5.4.5.7 Functionality
      • 5.4.5.8 Installation Type
      • 5.4.5.9 Equipment
      • 5.4.5.10 Mode
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Technology
      • 5.4.6.4 Component
      • 5.4.6.5 Application
      • 5.4.6.6 End User
      • 5.4.6.7 Functionality
      • 5.4.6.8 Installation Type
      • 5.4.6.9 Equipment
      • 5.4.6.10 Mode
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Technology
      • 5.4.7.4 Component
      • 5.4.7.5 Application
      • 5.4.7.6 End User
      • 5.4.7.7 Functionality
      • 5.4.7.8 Installation Type
      • 5.4.7.9 Equipment
      • 5.4.7.10 Mode
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Technology
      • 5.5.1.4 Component
      • 5.5.1.5 Application
      • 5.5.1.6 End User
      • 5.5.1.7 Functionality
      • 5.5.1.8 Installation Type
      • 5.5.1.9 Equipment
      • 5.5.1.10 Mode
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Technology
      • 5.5.2.4 Component
      • 5.5.2.5 Application
      • 5.5.2.6 End User
      • 5.5.2.7 Functionality
      • 5.5.2.8 Installation Type
      • 5.5.2.9 Equipment
      • 5.5.2.10 Mode
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Technology
      • 5.5.3.4 Component
      • 5.5.3.5 Application
      • 5.5.3.6 End User
      • 5.5.3.7 Functionality
      • 5.5.3.8 Installation Type
      • 5.5.3.9 Equipment
      • 5.5.3.10 Mode
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Technology
      • 5.5.4.4 Component
      • 5.5.4.5 Application
      • 5.5.4.6 End User
      • 5.5.4.7 Functionality
      • 5.5.4.8 Installation Type
      • 5.5.4.9 Equipment
      • 5.5.4.10 Mode
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Technology
      • 5.5.5.4 Component
      • 5.5.5.5 Application
      • 5.5.5.6 End User
      • 5.5.5.7 Functionality
      • 5.5.5.8 Installation Type
      • 5.5.5.9 Equipment
      • 5.5.5.10 Mode
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Technology
      • 5.5.6.4 Component
      • 5.5.6.5 Application
      • 5.5.6.6 End User
      • 5.5.6.7 Functionality
      • 5.5.6.8 Installation Type
      • 5.5.6.9 Equipment
      • 5.5.6.10 Mode
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Technology
      • 5.6.1.4 Component
      • 5.6.1.5 Application
      • 5.6.1.6 End User
      • 5.6.1.7 Functionality
      • 5.6.1.8 Installation Type
      • 5.6.1.9 Equipment
      • 5.6.1.10 Mode
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Technology
      • 5.6.2.4 Component
      • 5.6.2.5 Application
      • 5.6.2.6 End User
      • 5.6.2.7 Functionality
      • 5.6.2.8 Installation Type
      • 5.6.2.9 Equipment
      • 5.6.2.10 Mode
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Technology
      • 5.6.3.4 Component
      • 5.6.3.5 Application
      • 5.6.3.6 End User
      • 5.6.3.7 Functionality
      • 5.6.3.8 Installation Type
      • 5.6.3.9 Equipment
      • 5.6.3.10 Mode
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Technology
      • 5.6.4.4 Component
      • 5.6.4.5 Application
      • 5.6.4.6 End User
      • 5.6.4.7 Functionality
      • 5.6.4.8 Installation Type
      • 5.6.4.9 Equipment
      • 5.6.4.10 Mode
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Technology
      • 5.6.5.4 Component
      • 5.6.5.5 Application
      • 5.6.5.6 End User
      • 5.6.5.7 Functionality
      • 5.6.5.8 Installation Type
      • 5.6.5.9 Equipment
      • 5.6.5.10 Mode

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Tandem Diabetes Care
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Insulet Corporation
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Ypsomed Holding
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 SOOIL Development
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 MicroTech Medical
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Medtrum Technologies
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Valeritas
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Roche Diabetes Care
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Debiotech
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Diabeloop
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Beta Bionics
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 A. Menarini Diagnostics
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Cellnovo Group
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 DANA Diabecare
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Bigfoot Biomedical
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us